Stock listing

Ovid Therapeutics Inc.

Selected listing: 1OT · MUN · EUR · DE

Ovid Therapeutics Inc. (Munich:1OT), Health Technology. Latest release Sep 3, 2026: Ovid Therapeutics to Participate in Upcoming Investor Conferences.

1OT:MUNEURDEUpdated October 2, 2026

Ticker: Munich:1OT
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Munich
Currency: EUR

Latest news from Ovid Therapeutics Inc.

Ovid Therapeutics to Participate in Upcoming Investor Conferences

September 3, 2026

Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results

August 13, 2026

Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development

July 8, 2026

Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors

June 3, 2026

Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

May 12, 2026

All Ovid Therapeutics Inc. news →

Events

Replays

Ovid Therapeutics Inc. (OVID) Q4 2025 Earnings Call
Wed, Mar 18, 2026 · 08:30 AM ET
Watch

Research Ovid Therapeutics Inc.

Ovid Therapeutics Inc. company profile

View the public company page for Ovid Therapeutics Inc. on 6ix.

Ovid Therapeutics Inc. news

Read company news and market updates connected to Ovid Therapeutics Inc..

Ovid Therapeutics Inc. investor events

Find investor webinars, events, and replay context for Ovid Therapeutics Inc..